These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Antipsychotic effects of caerulein on chronic schizophrenia]. Moroharu T; Watanabe N; Ito M Seishin Shinkeigaku Zasshi; 1983; 85(9):611-5. PubMed ID: 6145173 [No Abstract] [Full Text] [Related]
29. [Evaluation of thiothixene in the therapy of chronic schizophrenia]. Romaszewska K; Piotrowski A Psychiatr Pol; 1970; 4(1):69-71. PubMed ID: 5421205 [No Abstract] [Full Text] [Related]
30. [Effects of verapamil on cardiac performance]. Câmpeanu A; Cerin G; Chira R; Pleşa O; Chirilă L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):87-96. PubMed ID: 6145210 [No Abstract] [Full Text] [Related]
31. Pharmacotherapy of chronic hospitalized schizophrenics: diagnosis and treatment. Ban TA; Guy W; Wilson WH Psychiatr J Univ Ott; 1984 Dec; 9(4):191-5. PubMed ID: 6151202 [No Abstract] [Full Text] [Related]
32. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia. Kong DS; Yeo SH Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613 [No Abstract] [Full Text] [Related]
33. [Verapamil for regulation of cardiac rhythm disorders. Experience with our own patients]. Arsov D; Serafimova E Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1290+. PubMed ID: 4098330 [No Abstract] [Full Text] [Related]
34. Evaluation of the drug 1-methyl-D-lysergic acid butanolamide or methysergide maleate in the treatment of chronic schizophrenia. Maire FW; Collins LG; Marks JB Int J Neuropsychiatry; 1967; 3(5):397-9. PubMed ID: 4866597 [No Abstract] [Full Text] [Related]
35. Fluoxetine augmentation of haloperidol in chronic schizophrenia. Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132 [No Abstract] [Full Text] [Related]
36. Thiothixene in chronic schizophrenia. A clinical trial. Yilmaz AH Hawaii Med J; 1971; 30(3):178-82. PubMed ID: 4935845 [No Abstract] [Full Text] [Related]
37. An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia. Nakajima S; Uchida H; Suzuki T; Tomita M; Tsunoda K; Kitta M; Takeuchi H; Nomura K; Watanabe K; Kashima H J Clin Psychopharmacol; 2007 Aug; 27(4):401-3. PubMed ID: 17632230 [No Abstract] [Full Text] [Related]
38. A controlled study of fluspirilene in chronic schizophrenia. Villeneuve A; Dogan K; Lachance R; Proulx C Curr Ther Res Clin Exp; 1970 Dec; 12(12):819-27. PubMed ID: 4994687 [No Abstract] [Full Text] [Related]
39. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics. Kurland AA; Dim BH; Olsson JE Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356 [No Abstract] [Full Text] [Related]
40. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Rowland E; McKenna WJ; Gülker H; Krikler DM Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]